BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23075769)

  • 1. The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP-protein cargos to the cytosol of eukaryotic cells.
    Mohammed AF; Abdul-Wahid A; Huang EH; Bolewska-Pedyczak E; Cydzik M; Broad AE; Gariépy J
    J Control Release; 2012 Nov; 164(1):58-64. PubMed ID: 23075769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A.
    Liu H; Lindbo S; Ding H; Altai M; Garousi J; Orlova A; Tolmachev V; Hober S; Gräslund T
    Int J Oncol; 2019 Jul; 55(1):309-319. PubMed ID: 31180549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of the plasmid for expression of ETA-EGFP fusion protein under control of the cytomegalovirus promoter and its effects in HeLa cells.
    Glinka EM; Andryushchenko AS; Sapozhnikov AM; Zatsepina OV
    Plasmid; 2009 Sep; 62(2):119-27. PubMed ID: 19527753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.
    Kessler C; Pardo A; Tur MK; Gattenlöhner S; Fischer R; Kolberg K; Barth S
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):2025-2038. PubMed ID: 28667390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.
    Gattenlöhner S; Jörissen H; Huhn M; Vincent A; Beeson D; Tzartos S; Mamalaki A; Etschmann B; Muller-Hermelink HK; Koscielniak E; Barth S; Marx A
    J Biomed Biotechnol; 2010; 2010():187621. PubMed ID: 20204062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrax toxin-mediated delivery of the Pseudomonas exotoxin A enzymatic domain to the cytosol of tumor cells via cleavable ubiquitin fusions.
    Bachran C; Morley T; Abdelazim S; Fattah RJ; Liu S; Leppla SH
    mBio; 2013 Apr; 4(3):e00201-13. PubMed ID: 23631917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to follow intracellular trafficking of cell-penetrating peptides.
    Pärnaste L; Arukuusk P; Zagato E; Braeckmans K; Langel Ü
    J Drug Target; 2016; 24(6):508-19. PubMed ID: 26460120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis of Pseudomonas exotoxin A within hepatic endosomes by cathepsins B and D produces fragments displaying in vitro ADP-ribosylating and apoptotic effects.
    El Hage T; Lorin S; Decottignies P; Djavaheri-Mergny M; Authier F
    FEBS J; 2010 Sep; 277(18):3735-49. PubMed ID: 20718861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A binding motif for Hsp90 in the A chains of ADP-ribosylating toxins that move from the endoplasmic reticulum to the cytosol.
    Kellner A; Taylor M; Banerjee T; Britt CBT; Teter K
    Cell Microbiol; 2019 Oct; 21(10):e13074. PubMed ID: 31231933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity.
    Martin-Killias P; Stefan N; Rothschild S; Plückthun A; Zangemeister-Wittke U
    Clin Cancer Res; 2011 Jan; 17(1):100-10. PubMed ID: 21075824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
    Arora N; Klimpel KR; Singh Y; Leppla SH
    J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization and translocation of a new chimeric protein composed of Pseudomonas aeruginosa exotoxin A and mouse dihydrofolate reductase as a model system.
    Guidi-Rontani C
    Protein Eng; 1996 Jul; 9(7):611-6. PubMed ID: 8844833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines.
    Patel SG; Sayers EJ; He L; Narayan R; Williams TL; Mills EM; Allemann RK; Luk LYP; Jones AT; Tsai YH
    Sci Rep; 2019 Apr; 9(1):6298. PubMed ID: 31000738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.
    Santajit S; Seesuay W; Mahasongkram K; Sookrung N; Ampawong S; Reamtong O; Diraphat P; Chaicumpa W; Indrawattana N
    Sci Rep; 2019 Oct; 9(1):14928. PubMed ID: 31624289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endosomolytic HA2 sequence.
    Liou JS; Liu BR; Martin AL; Huang YW; Chiang HJ; Lee HJ
    Peptides; 2012 Oct; 37(2):273-84. PubMed ID: 22898256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of ATP-dependent Pseudomonas exotoxin translocation from a late recycling compartment in lymphocyte intoxication procedure.
    Alami M; Taupiac MP; Reggio H; Bienvenüe A; Beaumelle B
    Mol Biol Cell; 1998 Feb; 9(2):387-402. PubMed ID: 9450963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin.
    Teter K; Holmes RK
    Infect Immun; 2002 Nov; 70(11):6172-9. PubMed ID: 12379695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.
    Weldon JE; Xiang L; Chertov O; Margulies I; Kreitman RJ; FitzGerald DJ; Pastan I
    Blood; 2009 Apr; 113(16):3792-800. PubMed ID: 18988862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos.
    Gentry SB; Nowak SJ; Ni X; Hill SA; Wade LR; Clark WR; Keelaghan AP; Morris DP; McMurry JL
    PLoS One; 2021; 16(9):e0254468. PubMed ID: 34473728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the
    Kaplan G; Mazor R; Lee F; Jang Y; Leshem Y; Pastan I
    Mol Cancer Ther; 2018 Jul; 17(7):1486-1493. PubMed ID: 29695631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.